A lyophilized research blend combining BPC-157 and TB-500 in a single vial. BPC-157 contributes localized regenerative signaling derived from gastric-protection biology; TB-500 contributes systemic, actin-mediated cell-migration and angiogenesis support.
The combination is studied for compounded effects in tissue repair protocols where both local and body-wide mechanisms are relevant.
- Combined local + systemic regeneration research
- Compounded musculoskeletal-repair studies
- Vascularization and tissue-remodeling investigation
- Anti-inflammatory cytokine modulation
- MW
- BPC-157: 1419.54 · TB-500: 4963.49
- Formula
- BPC-157: C₆₂H₉₈N₁₆O₂₂ · TB-500: C₂₁₂H₃₅₀N₅₆O₇₈S
Lyophilized blend at -20 °C in a desiccated environment. Reconstituted solution at 2–8 °C; discard after 14 days. Avoid repeated freeze-thaw.
For research and laboratory use only. Not for human or veterinary consumption.
How to run this compound.
Add bacteriostatic water to the sealed vial. Swirl — do not shake. Refrigerate after reconstitution.
Pre-blended vial. Reconstitute once — single subcutaneous injection delivers both peptides.
Run on the protocol schedule. The system rewards consistency over intensity.
Pair with complementary REFRAME lines. See suggestions below.